Logo image of FGEN

FIBROGEN INC (FGEN) Stock Analyst Ratings

NASDAQ:FGEN - Nasdaq - US31572Q8087 - Common Stock - Currency: USD

0.2639  -0.05 (-14.87%)

After market: 0.2699 +0.01 (+2.27%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to FGEN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.2. This target is 3765.1% above the current price.
FGEN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about FGEN.
In the previous month the buy percentage consensus was at a similar level.
FGEN was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

FGEN Historical Analyst RatingsFGEN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -102 -92 -82 -72 -62 -52 -42 -32 -22 -12 -2 5 10 15

Price Target & Forecast

Price Low Median Mean High 0.2610.1010.2010.2010.50 - 3,727.21% 3,765.10% 3,765.10% 3,878.78%

Related screens

FGEN Current Analyst RatingFGEN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-05-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-18 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-08 B of A Securities Downgrade Neutral -> Underperform
2023-06-27 Raymond James Downgrade Outperform -> Market Perform
2023-06-27 Goldman Sachs Maintains Sell -> Sell
2023-06-26 William Blair Downgrade Outperform -> Market Perform
2023-06-26 Stifel Downgrade Buy -> Hold
2023-06-26 Raymond James Downgrade Outperform -> Market Perform
2023-06-26 B of A Securities Downgrade Buy -> Neutral
2023-06-02 Stifel Upgrade Hold -> Buy
2023-02-28 Cowen & Co. Maintains Market Perform
2023-02-23 Goldman Sachs Maintains Sell
2023-02-21 Goldman Sachs Maintains Sell
2023-01-31 William Blair Upgrade Market Perform -> Outperform
2023-01-26 Raymond James Upgrade Market Perform -> Outperform
2023-01-05 B of A Securities Upgrade Neutral -> Buy
2022-11-08 Goldman Sachs Maintains Sell
2022-05-24 Goldman Sachs Maintains Sell
2022-03-01 Goldman Sachs Maintains Sell
2021-09-22 Goldman Sachs Downgrade Neutral -> Sell
2021-08-20 Raymond James Upgrade Underperform -> Market Perform
2021-08-10 SVB Leerink Maintains Outperform
2021-07-16 Stifel Downgrade Buy -> Hold
2021-07-16 B of A Securities Downgrade Buy -> Neutral
2021-04-07 Mizuho Downgrade Buy -> Neutral
2021-04-07 SVB Leerink Maintains Outperform
2021-04-07 JP Morgan Upgrade Underweight -> Neutral
2021-04-07 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-03-31 B of A Securities Upgrade Neutral -> Buy